Literature DB >> 35178280

Suspected Case of Drug-Induced Acute Respiratory Distress Syndrome following Trimethoprim-Sulfamethoxazole Treatment.

Julia Natterer1, Frida Rizzati1, Marie-Hélène Perez1, David Longchamp1, Vivianne Amiet1, Quentin DeHalleux2, Kim Dao3, Thomas Ferry1.   

Abstract

In this article, we reported the case of a child patient who was admitted to our PICU for severe acute respiratory distress syndrome (ARDS) while being treated with trimethoprim-sulfamethoxazole (TMP-SMX) for osteomyelitis. Based on the timing of exposure, lack of alternative explanations, and clinical course similar to previously described cases, we suspect that TMP-SMX may have triggered ARDS. Despite meeting criteria for extracorporeal membrane oxygenation cannulation, conservative management and lung recruitment with high-frequency percussive ventilation could avoid the latter. Thieme. All rights reserved.

Entities:  

Keywords:  acute respiratory distress syndrome; percussive ventilation; trimethoprim

Year:  2020        PMID: 35178280      PMCID: PMC8843409          DOI: 10.1055/s-0040-1714707

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  20 in total

1.  The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model.

Authors:  M-A Nay; J Mankikian; A Auvet; P-F Dequin; A Guillon
Journal:  Anaesthesia       Date:  2015-11-12       Impact factor: 6.955

2.  Trimethoprim-sulfamethoxazole therapy for children with acute osteomyelitis.

Authors:  Allison F Messina; Katie Namtu; Michelle Guild; Juan A Dumois; David M Berman
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference.

Authors: 
Journal:  Pediatr Crit Care Med       Date:  2015-06       Impact factor: 3.624

4.  High-frequency percussive ventilation as a salvage modality in adult respiratory distress syndrome: a preliminary study.

Authors:  Stephen M Paulsen; Garry W Killyon; David J Barillo
Journal:  Am Surg       Date:  2002-10       Impact factor: 0.688

5.  Hypersensitivity pneumonitis induced by trimethoprim.

Authors:  T Higgins; P M Niklasson
Journal:  BMJ       Date:  1990-05-19

6.  Interstitial lung disease during trimethoprim/sulfamethoxazole administration.

Authors:  Syota Yuzurio; Naokatsu Horita; Yutaro Shiota; Arihiko Kanehiro; Mitsune Tanimoto
Journal:  Acta Med Okayama       Date:  2010-06       Impact factor: 0.892

7.  High-frequency percussive ventilation improves oxygenation and ventilation in pediatric patients with acute respiratory failure.

Authors:  Nicole A Rizkalla; Cheryl L Dominick; Julie C Fitzgerald; Neal J Thomas; Nadir Yehya
Journal:  J Crit Care       Date:  2013-11-22       Impact factor: 3.425

8.  Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole.

Authors:  Jenna O Miller; Jane Taylor; Jennifer L Goldman
Journal:  Pediatrics       Date:  2019-06       Impact factor: 7.124

9.  Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.

Authors:  Thachanan Kongpan; Surakameth Mahasirimongkol; Parinya Konyoung; Sirimas Kanjanawart; Pansu Chumworathayi; Nuanjun Wichukchinda; Runglak Kidkeukarun; Suphanlinee Preechakul; Usanee Khunarkornsiri; Warawut Bamrungram; Butsaban Supharatwattanakun; Piroon Mootsikapun; Supanida Kwangsukstid; Sukanda Denjanta; Suda Vannaprasaht; Watcharee Rungapiromnan; Wimon Suwankesawong; Wongwiwat Tassaneeyakul; Wichittra Tassaneeyakul
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

10.  Pulmonary infiltrates and hypoxemia in patients with the acquired immunodeficiency syndrome re-exposed to trimethoprim-sulfamethoxazole.

Authors:  R C Silvestri; W A Jensen; J D Zibrak; R C Alexander; R M Rose
Journal:  Am Rev Respir Dis       Date:  1987-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.